周围神经膜瘤:一个诊断和治疗的挑战
Deviprasad Sulli1, Chandni Shankar2, Shruti G Raikar2
1Plastic Surgery, Yenepoya Medical College, Mangalore, IND.
Cureus
|April 22, 2024
概括
早期诊断和专业的外科护理改善了周围神经瘤的结果. 迅速转诊和微手术技术对于患者的康复和症状缓解至关重要.
科学领域:
- 在瘤学瘤学.
- 神经外科 神经外科
- 病理学 病理学 病理学
背景情况:
- 周围神经瘤是一种罕见的神经外皮软组织瘤.
- 虽然往往是良性的,但高达10%的人表现出恶性潜力.
- 临床表现因瘤的位置,大小和邻近结构的压缩而有所不同.
研究的目的:
- 为了强调外围神经瘤的多样化临床表现.
- 为应对临床医生面临的诊断挑战.
- 强调及时和适当的治疗转诊的重要性.
主要方法:
- 在2015年至2022年期间接受治疗的8名患者的回顾性分析.
- 详细的临床评估和手术管理.
- 使用放大镜完成瘤切除,以保存神经血管结构.
- 手术后的随访,以评估症状的消失.
主要成果:
- 平均诊断延迟时间为13个月.
- 常见的症状包括疼痛 (7/8) 和胀 (7/8);一名患者出现神经缺陷.
- 组织学发现发现了神经纤维瘤 (5/8),神经纤维瘤 (2/8),和一个恶性瘤.
- 手术后霍夫曼·提尼尔症状 (6/6) 改善,疼痛显著减少 (5/7无疼痛,2/7症状减少).
结论:
- 早期诊断和转诊专业中心对于在外围神经瘤管理中获得最佳结果至关重要.
- 建议经验丰富的专家使用微手术技术进行手术治疗,以治疗增殖性病变.
- 专业护理确保了功能的维护,并促进了患者的完全康复.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.